Cristian Massacesi Appointed Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb
Bristol Myers Squibb announced the appointment of Cristian Massacesi, M.D., as Executive…
Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Datroway: A Novel TROP2โDirected Therapy Approved for Lung Cancer
AstraZeneca and DaiichiโฏSankyoโs new antibody drug conjugate, Datroway (datopotamabโฏderuxtecan), has received accelerated…
AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA…
The Three Stages of Bone Marrow Transplantation: Dr. Kamol Iskandarov Explains | BMT
In this insightful episode, Dr. Kamol Iskandarov, a pediatric hematology-oncology specialist, shares…
MD Anderson Cancer Center names Jeffrey E. Lee as Chief Medical Executive
March 2025- The University of Texas MD Anderson Cancer Center announced thatย Jeffrey…
Pediatric Hematology & Cancer Care | Dr. muhammad faisal khanani | BMT
Join Dr. muhammad faisal khanani, Chief Division of Pediatric Hematology and oncology…
Cosmos Health appoints professor Dimitrios Trafalis as head of oncology
December 2024- Cosmos Health, a diversified, vertically integrated global healthcare group engaged…
2nd Annual ADSCC Bone Marrow Transplant and Cellular Therapy Congress 2024 to take place in Abu Dhabi
Abu Dhabi- October 2024- Under the Patronage of His Highness Sheikh Mansour…
New Study: Skin cancer incidence in young adults declines
September 2024- The risk of skin cancer, malignant melanoma, now appears to…
